Back to Results

MetaStat Inc (MTST)

MetaStat Inc. is a Boston-based healthcare company focused on precision medicine for cancer. The company develops therapeutic and diagnostic solutions designed to identify and address the MENA pathway, which it describes as a key driver of metastasis, treatment resistance, and cancer progression in solid tumors. Its pipeline includes the MENA diagnostic assay, a tissue-based quantitative immunofluorescence test, companion diagnostics intended to help assess responses to RTK inhibitor and anti-microtubule therapies, a liquid blood-based biopsy concept aimed at improving cancer detection and patient care, and the MetaSite Breast assay, an immunohistochemistry test related to tumor microenvironment sites. MetaStat also states that it is developing a prognostic diagnostic to help estimate metastatic risk. The company’s common stock trades on OTC Markets under the symbol MTST.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-MTST
Not available
Not available
Not available
Excellent
0.0%
319.729 K
Valuation • Fair Value

MetaStat Inc (OTC-MTST) Fair Value by Valuation Model

No usable valuation estimate is currently available for MetaStat Inc (OTC-MTST); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for MetaStat Inc (OTC-MTST). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for MetaStat Inc (OTC-MTST)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review MetaStat Inc (OTC-MTST) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for MetaStat Inc (OTC-MTST)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Excellent

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for MetaStat Inc (OTC-MTST). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for MetaStat Inc (OTC-MTST)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for MetaStat Inc (OTC-MTST). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

MetaStat Inc (OTC-MTST) Stock Forecast & Technical Outlook

Review MetaStat Inc (OTC-MTST) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for MetaStat Inc (OTC-MTST) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for MetaStat Inc (OTC-MTST) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for MetaStat Inc (OTC-MTST) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for MetaStat Inc (OTC-MTST) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for MetaStat Inc (OTC-MTST) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for MetaStat Inc (OTC-MTST)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, MetaStat Inc (OTC-MTST) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

MetaStat Inc (OTC-MTST) Stock FAQ

Data-supported answers about MetaStat Inc (OTC-MTST), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Excellent
Current financial-health read

A reliable fair value estimate is not currently available for MetaStat Inc (OTC-MTST). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for MetaStat Inc (OTC-MTST) is Excellent. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for MetaStat Inc (OTC-MTST).

The current market capitalization listed for MetaStat Inc is 319.729 K.

The ticker symbol for MetaStat Inc is OTC-MTST, and the stock is listed on OTC Markets.

MetaStat Inc (OTC-MTST) is listed on OTC Markets.

Similar Life Sciences Tools & Services Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

TMO NYSE Thermo Fisher Scientific Inc Fair Value Fair Market Cap 243.5 B
DHR NYSE Danaher Corporation Fair Value Fair Market Cap 155.4 B
A NYSE Agilent Technologies Inc Fair Value Fair Market Cap 47.155 B
IQV NYSE IQVIA Holdings Inc Fair Value Fair Market Cap 44.457 B
WAT NYSE Waters Corporation Fair Value Overvalued Market Cap 41.828 B
ILMN NASDAQ Illumina Inc Fair Value Overvalued Market Cap 37.366 B
MTD NYSE Mettler-Toledo International Inc Fair Value Fair Market Cap 29.87 B
WST NYSE West Pharmaceutical Services Inc Fair Value Fair Market Cap 26.116 B
MEDP NASDAQ Medpace Holdings Inc Fair Value Fair Market Cap 17.59 B
RVTY NYSE Revvity Inc Fair Value Fair Market Cap 15.991 B
TEM NASDAQ Tempus AI Inc Fair Value Overvalued Market Cap 13.928 B
CRL NYSE Charles River Laboratories Fair Value Fair Market Cap 13.611 B
ICLR NASDAQ ICON PLC Fair Value Fair Market Cap 12.894 B
TECH NASDAQ Bio-Techne Corp Fair Value Fair Market Cap 11.377 B
RGEN NASDAQ Repligen Corporation Fair Value Overvalued Market Cap 10.539 B
TXG NASDAQ 10X Genomics Inc Fair Value Overvalued Market Cap 10.514 B
AVTR NYSE Avantor Inc Fair Value Fair Market Cap 10.105 B
BIOB NYSE Bio-Rad Laboratories B Fair Value Fair Market Cap 10.076 B
BIO NYSE Bio-Rad Laboratories Inc Fair Value Fair Market Cap 10.076 B
BRKR NASDAQ Bruker Corporation Fair Value Fair Market Cap 9.326 B